Analystreport

Novocure Ltd (NASDAQ: NVCR) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a price target on the stock.

NovoCure Limited - Ordinary Shares  (NVCR) 
Last novocure limited - ordinary shares earnings: 4/30 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: novocure.com/investor-relations